Repurposed drug may extend survival in aggressive ovarian cancer, trial shows
Relacorilant, typically used to treat Cushing’s syndrome, could improve outcomes in platinum-resistant cases A drug originally used to treat a rare disease could extend the lives of patients with an aggressive form of ov